Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Experts caution that the evidence is mainly anecdotal, and there are potential risks such as liver or kidney issues and allergic reactions
As recent studies show the amount of people taking glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss, and not for managing type 2 diabetes as originally used, researchers have been examining these medications for potential positive and negative side effects
Semaglutide and tirzepatide do not directly cause hair loss
Plant-derived bioactive compounds and essential oils show broad therapeutic potential for treating infections, inflammation, and chronic diseases
Weight loss before pregnancy offers health benefits for both mother and baby
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor Tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
US$ 21.32
US$ 25.76
US$ 28.23
US$ 26.16
US$ 24.91
US$ 22.59
US$ 27.47
US$ 20.30
US$ 28.64
US$ 20.94
